Use of OCT in AMD Clinical Trials

4DMT Planning Phase 3 Clinical Trial for Wet AMD Gene TherapyПодробнее

Exploring Valeda light therapy for AMDПодробнее

Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility & Advanced AI AnalysisПодробнее

MERIT Webinar: OCT Evaluation of Neovascular AMD in Clinical Trials – A Reading Center PerspectiveПодробнее

Blindness and Clinical Trials Webinar Presented by Accessible Pharmacy ServicesПодробнее

New treatments for macular degeneration! But are they SAFE?Подробнее

Elon Musk's Bionic Eyes Are Here.Подробнее

Why Use a Clinical Trial Management System?Подробнее

VISIONS 2024 | Clinical & Research Updates: Retinitis PigmentosaПодробнее

How Allgenesis Evaluated Unique Endpoints to Advance its Phase 2 DME StudyПодробнее

The Age-Related Macular Degeneration (AMD) Clinical Trial LandscapeПодробнее

Diabetes and your eyes: Latest treatments and research.Подробнее

Webinar: OCT in macular disease - practical tips and case studiesПодробнее

RPB Lunch & Learn: Eye on Retinitis PigmentosaПодробнее

Therapies for late-stage dry AMD, or ‘geographic atrophy' with Clare BaileyПодробнее

Lecture: Gene Therapy and Delivery Strategies for AMD and Diabetic RetinopathyПодробнее

CLINICAL TRIALS IN DMEПодробнее

Innovation In Clinical Trials – Using AI in Oct ScansПодробнее

AI and Machine Learning in Dry AMD Clinical TrialsПодробнее

Lecture: The Therapeutic Pipeline for Age-Related Macular Degeneration and Diabetic Macular EdemaПодробнее